Table 5.

Impact of the inoculation rate (Vac.) and the efficacy ($ϵ$) of the vaccine on the peak of the infected (I) and hospitalized (H) subpopulations. In addition, on the deaths (D) and recovered (R) cases. In these scenarios, the infectiousness of the asymptomatic individuals relative to symptomatic is 100% (${\beta }_A={\beta }_I$), and the percentage of infections that are asymptomatic is 40%.

	Vac.	2 Million		4 Million
	Eff. ($\mathit{ϵ}$)	94%	80%	94%	80%
Pop	Trans. (${\mathit{\beta }}_{\mathit{I}}$)
I	0.2	5.542887 $\times {10}^6$	5.637083 $\times {10}^6$	4.625919 $\times {10}^6$	4.799400 $\times {10}^6$
	0.22	8.694897 $\times {10}^6$	8.840743 $\times {10}^6$	7.180468 $\times {10}^6$	7.497133 $\times {10}^6$
H	0.2	3.426932 $\times {10}^5$	3.485607 $\times {10}^5$	2.855083 $\times {10}^5$	2.963821 $\times {10}^5$
	0.22	5.335221 $\times {10}^5$	5.425334 $\times {10}^5$	4.403929 $\times {10}^5$	4.599537 $\times {10}^5$
R	0.2	1.289053 $\times {10}^8$	1.320051 $\times {10}^8$	9.968921 $\times {10}^7$	1.056169 $\times {10}^8$
	0.22	1.624433 $\times {10}^8$	1.656592 $\times {10}^8$	1.307745 $\times {10}^8$	1.380529 $\times {10}^8$
D	0.2	4.768158 $\times {10}^5$	4.897834 $\times {10}^5$	3.544676 $\times {10}^5$	3.793021 $\times {10}^5$
	0.22	6.175980 $\times {10}^5$	6.310708 $\times {10}^5$	4.848819 $\times {10}^5$	5.153864 $\times {10}^5$